REFERENCES
1. Newton M, Scott K, Troein P. EFPIA patients W.A.I.T. indicator 2021 survey. Available from: https://www.efpia.eu/media/636821/efpia-patients-wait-indicator-final.pdf [Last accessed on 6 Jun 2022].
2. HAS. Transparency committee doctrine. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2019-07/doctrine_de_la_commission_de_la_transparence_-_version_anglaise.pdf [Last accessed on 6 Jun 2022].
3. HAS. Real-world studies for the assessment of medicinal products and medical devices. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2021-10/real-world_studies_for_the_assessment_of_medicinal_products_and_medical_devices.pdf [Last accessed on 6 Jun 2022].
4. PFIZER. Plaidoyer pour une reconnaissance de la perspective patient dans l’évaluation des prodiits de sante. Available from: https://www.pfizer.fr/sites/default/files/inline-files/Plaidoyer%20pour%20la%20reconnaissance%20de%20la%20perspective%20patient%20dans%20l%27%C3%A9valuationVF.pdf [Last accessed on 6 Jun 2022].
5. Gesbert C, André-Vert J, Guerrier M, et al. The contribution of French patient and consumer groups to health technology assessments over a 2-year period: an observational retrospective study. Int J Technol Assess Health Care 2021;37:e48.
